Archive for December 2nd, 2009

Rubicon Tout Lifts Shares (RBCN)

Rubicon Technology, Inc. (NASDAQ: RBCN) just took off like a rocket for a quick burst after it was touted on CNBC as one of the beneficiaries of pricing strength due to materials supply constraints.  The interview featuring this one just ended at 1:28 PM EST…. At 1:29 we have shares up 6.8% at $19.29 after [...]

Stem Cell Shares Launch on NIH (STEM, GERN, ASTM)

We are seeing a sharp run in some of the stem cell stocks after a National Institutes of Health approval on new embryonic stem cell lines. StemCells Inc. (NASDAQ: STEM) up 5.5% at $1.14; 52-week range $0.89 to $3.07; market cap $135 million Geron Corporation (NASDAQ: GERN) up 4.8% at $5.70; 52-week range $3.00 to [...]

Trading Alert RF Micro Devices (RFMD)

RF Micro Devices Inc. (NASDAQ: RFMD) is running up after that stock’s analyst rating was raised to Buy at UBS.  As this is a low priced tech stock, you can imagine that the volume will be picking up this morning.  At 8:32 AM EST we have seen 108,000 shares trade hands and the stock is [...]

Dyax Beating 52-Week High; Has Leaderboard (DYAX)

Dyax Corp. (NASDAQ: DYAX) is soaring after the comapny won FDA approval to market its Kalbitor for the treatment of genetic hereditary angioedema in patients 16 years and up.  This is a rare disorder caused by fluids building up outside of blood vessels and causes swelling in extremities, the face, airway, and internal organs.  This [...]

Novavax Porks Swine Flu (NVAX)

Novavax, Inc. (NASDAQ: NVAX) is trading up again on swine flu or H1N1 news.  The company issued a press release showing positive clinical results from a pivotal study of H1N1 influenza vaccine in Mexico.  At 8:21 AM EST we have seen 319,000 shares trade hands and the stock is up 7.1% at $3.44.  Average volume [...]

Somaxon Volatility Continues (SOMX)

Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX) has been volatile as hell in recent days ahead of an FDA decision due tomorrow for the company’s Silenor as an approved insomnia treatment.  The stock was up big on Monday, but gave back some gains yesterday after it initially gapped up higher and this follows last week’s moves. Day. [...]

Diedrich… Coffee War Calls For Blood (DDRX, GMCR, PEET)

Diedrich Coffee Inc. (NASDAQ: DDRX) announced that the Green Mountain Coffee Roasters (NASDAQ: GMCR) re-upped buyout offer of $35 per share in cash is a better deal than the Peet’s Coffee & Tea (PEET) offer.  DDRX is actually trading above the buyout price because of the chance that PEET will make yet another offer.  DDRX [...]

Hemispherix Dead Tired (HEB)

Hemispherx Biopharma, Inc. (AMEX: HEB) lost almost half of its value last night and is still getting crushed this morning.  The company announced that the FDA has denied its Ampligen treatment as a treatment for chronic fatigue syndrome.  The FDA said the two key studies did not prove the drugs efficacy and recommended that another [...]